Glossary

A package that will pass a test protocol administered by the U.S. Consumer Product Safety Commission (CPSC).

Related Breaking News

Promotions & Moves

Akebia Therapeutics Names CMO

Jain to lead clinical development of the company’s HIF pipeline
GMPs/GCPs | Inspections | Regulatory Affairs | Trials & Filings

Lion To Advance TIL to Phase III

Metastatic melanoma treatment posts positive Phase II results
Gil Roth
Analytical Services | Bioanalytical Services | Bioassay Development | Fill/Finish | Toxicology

Compliance Packaging Update

Patient adherence remains a challenge
Gil Y. Roth, Contract Pharma
CR

...
Genmab Achieves Positive Results in NHL Study

Genmab achieved positive results from a Phase II study of Arzerra (ofatumumab) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in front line follicular non-Hodgkin's lymphoma (NHL).